The risks and benefits of intravenous tissue plasminogen activator and endovascular thrombectomy are discussed in the following slides.
 Â
Neuro News Roundup: Stroke Risks & Treatments
Acute stroke patients on anti-platelet therapy are at a higher risk of intracranial hemorrhage after intravenous tissue plasminogen activator (tPA) than those not taking antiplatelet agents, but the increased risk is small and functional outcomes are better, according to a new observational study.
Assessing Bleeding Risk with tPA
More Bleeding, But Better Function After tPA
Acute ischemic stroke patients show markedly improved functional independence with endovascular treatment, according to a new meta-analysis.
Endovascular Thrombectomy for Acute Ischemic Stroke
Endovascular Therapy Benefits
Diagnosing stroke in patients with acute dizziness can be accomplished with a combination of readily available clinical information, according to a new study.
